Navigation
Market Outlook Stock Screener Dividend Calendar Event Calendar Rating of shares Markets News
Try free

Applied Genetic Technologies

NASDAQ AGTC
- - -%
Today share price
USA
Sector: Healthcare Industry: Biotechnology
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 15 %
Market cap

Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.

26.62M
EV

Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
-55.05K
Beta

Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
2.14
Shares

Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
67.63M
YTD

Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
-

Upcoming events Applied Genetic Technologies

All events
No upcoming events scheduled

Overview

Financials

Key Metrics

Dividends

Industry overview

Events

Stock chart Applied Genetic Technologies

Stock analysis Applied Genetic Technologies

Indicator Company Industry
P/E (LTM)

Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-0.38 28.84
P/BV (LTM)

Shows the ratio of the market price of the share to the current book value.
0.90 4.35
EV/EBITDA (LTM)

Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
- 10.00
Net Debt/EBITDA (LTM)

A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.41 0.65
ROE (LTM)

Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-398.02 7.67

Price change Applied Genetic Technologies per year

2.57$ 9.67$
Min Max

Summary analysis Applied Genetic Technologies

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Applied Genetic Technologies

Revenue and net income Applied Genetic Technologies

All parameters

Stock news Applied Genetic Technologies

All news
18 July 2022 в 14:10

Applied Genetic Technologies stock price target cut to $2 from $6 at Wedbush

About company Applied Genetic Technologies

Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Phase I/II clinical trials; and achromatopsia that is in Phase I/II clinical trials. It is also developing an optogenetic product candidate to treat advanced retinal disease. In addition, the company has initiated one preclinical program in otology; and two preclinical programs in targeting central nervous system disorders, including frontotemporal dementia and amyotrophic lateral sclerosis. It has collaboration agreements with University of Florida; Bionic Sight, LLC; and Otonomy, Inc. Applied Genetic Technologies Corporation was incorporated in 1999 and is headquartered in Alachua, Florida.
Address:
14193 NW 119th Terrace, Alachua, FL, United States, 32615
Company name: Applied Genetic Technologies
Issuer ticker: AGTC
ISIN: US03820J1007
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2014-03-27
Sector: Healthcare
Industry: Biotechnology
Site: https://agtc.com

On which stock exchange are Applied Genetic Technologies (AGTC) stocks traded?

Applied Genetic Technologies (AGTC) stocks are traded on NASDAQ.

What is the ticker of Applied Genetic Technologies stocks (AGTC)?

The stock ticker of Applied Genetic Technologies’s stocks or in other words, the code is AGTC. The stocks are currently listed on the NASDAQ exchange.

In which sector and industry does Applied Genetic Technologies (AGTC) operate?

According to the GICS (Global Industry Classification Standard) classification developed jointly by MSCI and Standard & Poor's, Applied Genetic Technologies (AGTC) belongs to the «Healthcare» sector and the «Biotechnology» industry.

In what currency are Applied Genetic Technologies (AGTC) stocks traded?

Applied Genetic Technologies (AGTC) stocks are traded on the NASDAQ exchange in dollars.

What is the price of Applied Genetic Technologies (AGTC) stocks today?

The current price of Applied Genetic Technologies stocks on 20.05.2024 is dollars. per share.

What is the dynamics of Applied Genetic Technologies (AGTC) stocks from the beginning of the year?

Applied Genetic Technologies (AGTC) quotes have increased by 0% from the beginning of the year up to dollars. per 1 stocks.

How much did Applied Genetic Technologies (AGTC) stocks increase in мае 2024?

This month Applied Genetic Technologies (AGTC) quotes have increased by 0% to dollars. per share.

How much are Applied Genetic Technologies (AGTC) stocks worth?

Today, on October, 20.05.2024 Applied Genetic Technologies’s (AGTC) stocks cost dollars..

What is the market capitalization of Applied Genetic Technologies (AGTC)?

Capitalization is the market value of Applied Genetic Technologies (AGTC) is calculated as the number of issued stocks multiplied on the current quotation price. Thus, on 20.05.2024, the market capitalization of Applied Genetic Technologies (AGTC) is estimated at about 26619955 dollars.